Journals / Eurasian Journal of Medical Investigation / 2021 / Cilt: 5 - Sayı: 2

Genetic Abnormalities Detected in Non-Hodgkin Lymphoma

Pages
283–288
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Despite including small number of patients and heterogeneous histological NHL subtypes, our study mayprovide contribution to the frequency and type of genetic abnormalities in patients with NHL in Turkey.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: To investigate the association between clinical features and fluorescence in situ hybridization (FISH) resultsof patients with non -Hodgkin lymphoma (NHL).
📊
Key Findings & Data:Results: Genetic abnormality was present in 33 of 56 patients.
💡
Conclusion & Impact:Conclusion: Despite including small number of patients and heterogeneous histological NHL subtypes, our study mayprovide contribution to the frequency and type of genetic abnormalities in patients with NHL in Turkey.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: To investigate the association between clinical features and fluorescence in situ hybridization (FISH) resultsof patients with non -Hodgkin lymphoma (NHL). The advances in molecular biology, cytogenetics and immunology facilitated the understanding of the pathogenesisof lymphoma. Although there are some basic prognostic indicators, the prognostic importance of genetic factors isgradually increasing. Methods: Fifty six patients who underwent genetic analysis before therapy, were evaluated retrospectively. Deparaf finized lymph node sections were used. Patients were divided into two groups according to the presence of geneticdisorder. The groups were compared in terms of clinical features, laboratory parameters and survival. Results: Genetic abnormality was present in 33 of 56 patients. The most common genetic abnormality was MYC/IGH2rearrangement. There was no difference between the survival of the groups. There was a positive correlation between Bsymptoms and the presence of genetic disorder and a negative correlation between leukocyte count and the presenceof genetic abnormality. Conclusion: Despite including small number of patients and heterogeneous histological NHL subtypes, our study mayprovide contribution to the frequency and type of genetic abnormalities in patients with NHL in Turkey.

🔖

Cite This Article

GÜNDÜZ, E., ARAS, B. D., BULDUK, T., EMİR, B., IŞIKSOY, S. (2022). Genetic Abnormalities Detected in Non-Hodgkin Lymphoma. Eurasian Journal of Medical Investigation, Cilt: 5 - Sayı: 2, 283–288. https://ajindex.com/articles/508608

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Offit K, Wong G, Filippa DA, Tao Y, Chaganti RS. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: clinical correlations. Blood 1991;7:1508–15
  2. Johansson B, Mertens F, Mitelman F. Cytogenetic evolution patterns in non-Hodgkin's lymphoma. Blood 1995;86:3905– 14
  3. Wang L, Lawrence MS, Wan Y, Stojanov P, Sougnez C, Stevenson K, et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med 2011;365:2497–506
  4. Couronné L, Bastard C, Bernard OA. TET2 and DNMT3A mutations in human T-cell lymphoma. N Engl J Med 2012;366:95–6
  5. Rossi D, Bruscaggin A, Spina V, Rasi S, Khiabanian H, Messina M, et al. Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness. Blood 2011;118:6904–8
  6. Kaneko Y, Rowley JD, Variakojis D, Haren JM, Ueshima Y, Daly K, et al. Prognostic implications of karyotype and morphology in patients with non-Hodgkin's lymphoma. Int J Cancer 1983;32:683–92
  7. Bloomfield CD, Arthur DC, Frizzera G, Levine EG, Peterson BA, Gajl-Peczalska KJ. Nonrandom chromosome abnormalities in lymphoma. Cancer Res 1983;43:2975–84
  8. Levine EG, Arthur DC, Frizzera G, Peterson BA, Hurd DD, Bloomfield CD. There are differences in cytogenetic abnormalities among histologic subtypes of the non-Hodgkin's lymphomas. Blood 1985;66:1414–22
  9. Koduru PR, Filippa DA, Richardson ME, Jhanwar SC, Chaganti SR, Koziner B, et al. Cytogenetic and histologic correlations in malignant lymphoma. Blood 1987;69:97–102
  10. Levine EG, Arthur DC, Gajl-Peczalska KJ, LeBien TW, Peterson BA, Hurd DD, et al. Correlations between immunological phenotype and karyotype in malignant lymphoma. Cancer Res. 1986;46:6481–8 11. Richardson ME, Chen QG, Filippa DA, Offit K, Hampton A, Koduru PR, et al. Intermediate- to high-grade histology of lymphomas carrying t(14;18) is associated with additional nonrandom chromosome changes. Blood 1987;70:444–7
  11. Armitage JO, Sanger WG, Weisenburger DD, Harrington DS, Linder J, Bierman PJ, et al. Correlation of secondary cytogenetic abnormalities with histologic appearance in non-Hodgkin's lymphomas bearing t(14;18)(q32;q21). J Natl Cancer Inst 1988;80:576–80
  12. Kristoffersson U, Heim S, Mandahl N, Olsson H, Ranstam J, Akerman M, et al. Prognostic implication of cytogenetic findings in 106 patients with non-Hodgkin lymphoma. Cancer Genet Cytogenet 1987;25:55–64
  13. Levine EG, Arthur DC, Frizzera G, Pet